CIK 0001368514
- Large accelerated filer
ADMA BIOLOGICS, INC.
Sign in to watch- Ticker
- ADMA
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 562590442
- Phone
- +1 201-478-5552
- Business address
- C/O ADMA BIOLOGICS, INC., 465 STATE ROUTE 17, RAMSEY, NJ, 07446
- Former names
- R&R ACQUISITION VI, INC
- 4 Open-market buy Director bought 100,000 shares at $1.00 ($100,000)
- 4 Open-market buy EVP, CFO bought 30,000 shares at $1.00 ($30,000)
- 4 Open-market buy President and CEO bought 350,000 shares at $1.00 ($350,000)
- 4 Derivatives Options or other derivatives
- 3 Insider Initial Statement of Ownership
- 4 Grant or award EVP, CFO acquired 900,000 shares (grant or award)
- 4 Grant or award President and CEO acquired 1,650,000 shares (grant or award)
- 4 Open-market sale 10% owner sold 260,603 shares at an average $1.15 ($299,236)
- 4 Open-market sale 10% owner sold 500,000 shares at an average $1.25 ($622,500)
- 4 Open-market sale 10% owner sold 780,000 shares at $1.27 ($990,600)
- 4 Open-market sale 10% owner sold 1,781,824 shares at an average $1.31 ($2,333,781)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Grant or award President and CEO acquired 221,447 shares (grant or award)
- 4 Grant or award EVP, CSO and CMO acquired 64,361 shares (grant or award)
- 4 Grant or award EVP, CFO acquired 63,936 shares (grant or award)
- 4 Open-market buy Director bought 2,200 shares at $2.29 ($5,038)
Page 8 of 19 · 362 filings